UBS Group’s United States Antimony UAMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.6M | Buy |
2,012,576
+728,940
| +57% | +$6.35M | ﹤0.01% | 2729 |
|
|
2025
Q4 | $6.44M | Buy |
1,283,636
+1,034,880
| +416% | +$8.13M | ﹤0.01% | 3763 |
|
|
2025
Q3 | $1.54M | Buy |
248,756
+53,667
| +28% | +$224K | ﹤0.01% | 5205 |
|
|
2025
Q2 | $425K | Buy |
195,089
+109,638
| +128% | +$311K | ﹤0.01% | 6141 |
|
|
2025
Q1 | $188K | Buy |
85,451
+72,275
| +549% | +$125K | ﹤0.01% | 6598 |
|
|
2024
Q4 | $23.3K | Sell |
13,176
-238,954
| -95% | -$240K | ﹤0.01% | 7779 |
|
|
2024
Q3 | $192K | Buy |
252,130
+250,425
| +14,688% | +$126K | ﹤0.01% | 5903 |
|
|
2024
Q2 | $573 | Buy |
+1,705
| New | +$475 | ﹤0.01% | 8860 |
|
|
2024
Q1 | – | Sell |
-1,000
| Closed | -$249 | – | 10036 |
|
|
2023
Q4 | $249 | Buy |
+1,000
| New | +$300 | ﹤0.01% | 8772 |
|
|
2023
Q1 | – | Sell |
-10,000
| Closed | -$4.9K | – | 10393 |
|
|
2022
Q4 | $4.9K | Sell |
10,000
-9,047
| -47% | -$3.5K | ﹤0.01% | 9254 |
|
|
2022
Q3 | $7K | Buy |
+19,047
| New | +$8.29K | ﹤0.01% | 8911 |
|
|
2022
Q2 | – | Sell |
-14,727
| Closed | -$10K | – | 10960 |
|
|
2022
Q1 | $10K | Sell |
14,727
-52,981
| -78% | -$25.9K | ﹤0.01% | 8445 |
|
|
2021
Q4 | $34K | Buy |
67,708
+46,898
| +225% | +$34.5K | ﹤0.01% | 7276 |
|
|
2021
Q3 | $19K | Buy |
20,810
+16,574
| +391% | +$15.3K | ﹤0.01% | 7225 |
|
|
2021
Q2 | $4K | Buy |
+4,236
| New | +$3.93K | ﹤0.01% | 8696 |
|
|
2021
Q1 | – | Sell |
-14,002
| Closed | -$7K | – | 9479 |
|
|
2020
Q4 | $7K | Sell |
14,002
-18,997
| -58% | -$7.72K | ﹤0.01% | 7706 |
|
|
2020
Q3 | $10K | Buy |
32,999
+26,138
| +381% | +$11.9K | ﹤0.01% | 6866 |
|
|
2020
Q2 | $3K | Sell |
6,861
-9,937
| -59% | -$3.82K | ﹤0.01% | 7560 |
|
|
2020
Q1 | $6K | Sell |
16,798
-17,580
| -51% | -$6.65K | ﹤0.01% | 7237 |
|
|
2019
Q4 | $13K | Buy |
34,378
+24,093
| +234% | +$11.1K | ﹤0.01% | 7152 |
|
|
2019
Q3 | $6K | Buy |
+10,285
| New | +$6.67K | ﹤0.01% | 7428 |
|
|
2019
Q2 | – | Sell |
-12,956
| Closed | -$6K | – | 8169 |
|
|
2019
Q1 | $6K | Buy |
+12,956
| New | +$7.38K | ﹤0.01% | 7102 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | – | – | 8303 |
|
|
2018
Q3 | $0 | Sell |
100
-6,482
| -98% | -$3.91K | ﹤0.01% | 8273 |
|
|
2018
Q2 | $3K | Buy |
6,582
+6,338
| +2,598% | +$2.1K | ﹤0.01% | 7649 |
|
|
2018
Q1 | $0 | Sell |
244
-17,004
| -99% | -$5.04K | ﹤0.01% | 8175 |
|
|
2017
Q4 | $6K | Buy |
17,248
+12,429
| +258% | +$3.27K | ﹤0.01% | 7318 |
|
|
2017
Q3 | $1K | Buy |
4,819
+4,755
| +7,430% | +$1.57K | ﹤0.01% | 7592 |
|
|
2017
Q2 | $0 | Buy |
+64
| New | +$27 | ﹤0.01% | 7992 |
|
|
2016
Q4 | – | Sell |
-7,049
| Closed | -$3K | – | 8043 |
|
|
2016
Q3 | $3K | Buy |
+7,049
| New | +$2.56K | ﹤0.01% | 7304 |
|
|
2016
Q1 | – | Sell |
-6,375
| Closed | -$2K | – | 8196 |
|
|
2015
Q4 | $2K | Buy |
6,375
+947
| +17% | +$322 | ﹤0.01% | 8031 |
|
|
2015
Q3 | $2K | Buy |
5,428
+4,765
| +719% | +$2.7K | ﹤0.01% | 8102 |
|
|
2015
Q2 | $0 | Sell |
663
-3,746
| -85% | -$3.5K | ﹤0.01% | 8840 |
|
|
2015
Q1 | $3K | Buy |
+4,409
| New | +$2.82K | ﹤0.01% | 8343 |
|
Other funds holding UAMY
DCM
VCM
HRCM
UBS Group's UAMY Position: Q1 2026 in Review
UBS Group increased its United States Antimony (UAMY) stake by 57% in Q1 2026, buying an estimated $6.35M and bringing the position to 2,012,576 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2729.
UBS Group first reported a position in UAMY in Q1 2015 and has held it in 33 quarters since. 234 funds tracked by Wall St. Rank hold UAMY as of Q1 2026.
- UBS Group held 2,012,576 shares of United States Antimony worth $17.6M as of Q1 2026.
- UBS Group bought 728,940 United States Antimony shares in Q1 2026, an estimated $6.35M.
- United States Antimony made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2729 holding.
- UBS Group first reported a position in United States Antimony in Q1 2015 and has held it in 33 quarters since.
- 234 funds tracked by Wall St. Rank held United States Antimony as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.